RSS Atom • ISSN 2046-9373 • Subscribe • About
Antiretrovirals
- Similar efficacy and a few gender related differences in side effects with rilpivirine vs efavirenz at 96-weeks Antiretrovirals - Conference reports - PMTCT and maternal health - Intl Workshop on HIV and Women 2nd 2011 - 28 February 2012
- The effect of BMI on efficacy, safety and tolerability of lopinavir/r in women Antiretrovirals - Conference reports - Women's health - Intl Workshop on HIV and Women 2nd 2011 - 28 February 2012
- Poorer adherence and loss to follow up in Kenyan women who are pregnant when enrolled to ART programmes Antiretrovirals - Conference reports - PMTCT and maternal health - Intl Workshop on HIV and Women 2nd 2011 - 28 February 2012
- Raltegravir achieves superiority over efavirenz after four years Antiretrovirals - Conference reports - EACS 13 Belgrade 2011 - 28 February 2012
- Intracellular raltegravir concentrations better with twice-daily than once-daily dosing Antiretrovirals - Conference reports - ICAAC 51th Chicago 2011 - 28 February 2012
- Efavirenz dose increase to 800 mg QD with rifampin in patients >50 kg Antiretrovirals - 28 February 2012
- Lopinavir concentrations suboptimal at reduced dose of lopinavir/ritonavir 200/50 mg twice daily Antiretrovirals - PK and drug interactions - 28 February 2012
- Switching to 50mg ritonavir dose for selected protease inhibitors Antiretrovirals - PK and drug interactions - 28 February 2012
- BHIVA guidelines for the routine investigation and monitoring of adult HIV-1-infected individuals 2011 Antiretrovirals - Guidelines - 28 February 2012
- Draft BHIVA ARV treatment guidelines online for comment until 5 March Antiretrovirals - Guidelines - 28 February 2012
- Draft BHIVA pregnancy guidelines online for comment until 5 March Antiretrovirals - Guidelines - 28 February 2012
- US guidelines (DHHS) update recommendations for first-line combinations (October 2011) Antiretrovirals - 28 February 2012
- Treatment is prevention: ARV treatment in HPTN-052 reduces transmission by at least 96%: single transmission in treatment arm occurred prior to viral suppression Antiretrovirals - Conference reports - Prevention - Transmission - IAS 6 Rome 2011 - 15 August 2011
- Daily oral tenofovir/FTC PrEP reduces heterosexual transmission by 63% in the TDF2 study Antiretrovirals - Conference reports - Prevention - Transmission - IAS 6 Rome 2011 - 15 August 2011
- Tenofovir/FTC vs tenofovir as daily oral PrEP: preliminary results from Partners PrEP Antiretrovirals - Conference reports - Prevention - Transmission - IAS 6 Rome 2011 - 15 August 2011
- Elvitegravir vs raltegravir: 48 week results in treatment-experienced patients Antiretrovirals - Conference reports - IAS 6 Rome 2011 - 15 August 2011
- Dolutegravir: 48 week results from phase II study in treatment-naïve patients Antiretrovirals - Conference reports - IAS 6 Rome 2011 - 15 August 2011
- Lersivirine: 48 week results compared to efavirenz in phase 2 treatment-naïve study Antiretrovirals - Conference reports - IAS 6 Rome 2011 - 15 August 2011
- SPARTAC trial: treatment in primary infection for 48 weeks shows small delay in disease progression Antiretrovirals - Conference reports - IAS 6 Rome 2011 - 15 August 2011
- Paediatric antiretroviral pipeline: darunavir and raltegravir Antiretrovirals - Conference reports - Paediatric care - CROI 18 (Retrovirus) Boston 2011 - 15 August 2011
- FDA approve new NNRTI-based fixed dose combination of rilpivirine/tenofovir/FTC (Complera) in the US Antiretrovirals - 15 August 2011
- Immune-based treatment increases HIV-resistant CD4 cells in phase 1 study Antiretrovirals - Conference reports - CROI 18 (Retrovirus) Boston 2011 - 19 May 2011
- Antiretroviral prevention: oral PrEP, gels and treatment studies Antiretrovirals - Conference reports - CROI 18 (Retrovirus) Boston 2011 - 19 May 2011
- Further efficacy analyses from the iPrEx study Antiretrovirals - Conference reports - CROI 18 (Retrovirus) Boston 2011 - 19 May 2011
- Topical gels as PEP and PrEP: animal and human studies Antiretrovirals - Conference reports - CROI 18 (Retrovirus) Boston 2011 - 19 May 2011
- Maternal risk following short course HAART Antiretrovirals - Conference reports - PMTCT and maternal health - CROI 18 (Retrovirus) Boston 2011 - 19 May 2011
- Pre-term delivery and HAART Antiretrovirals - Conference reports - PMTCT and maternal health - CROI 18 (Retrovirus) Boston 2011 - 19 May 2011
- HAART more effective than AZT monotherapy in the Botswana PMTCT programme Antiretrovirals - Conference reports - PMTCT and maternal health - CROI 18 (Retrovirus) Boston 2011 - 19 May 2011
- Lopinavir/r monotherapy for PMTCT Antiretrovirals - Conference reports - PMTCT and maternal health - CROI 18 (Retrovirus) Boston 2011 - 19 May 2011
- When to start ART in patients co-infected with TB: results from two trials presented at CROI Antiretrovirals - Conference reports - TB coinfection - CROI 18 (Retrovirus) Boston 2011 - 19 May 2011
- Tenofovir associated with fewer side-effect related switches compared to AZT or d4T in first-line treatment Antiretrovirals - Side effects - 19 May 2011
- London HIV Consortium issues new guidelines for ARV prescribing Antiretrovirals - Guidelines - 19 May 2011
- Lopinavir/ritonavir: women versus men Antiretrovirals - Conference reports - Women's health - Intl Workshop on HIV and Women 1st 2011 - 22 January 2011
- Quality of life in the GRACE study Antiretrovirals - Conference reports - Women's health - Intl Workshop on HIV and Women 1st 2011 - 22 January 2011
- Antiretroviral pharmacokinetics in women with undetectable viral load Antiretrovirals - Conference reports - Women's health - Intl Workshop on HIV and Women 1st 2011 - 22 January 2011
- No association between bone mineral density and lipodystrophy in women receiving antiretroviral therapy Antiretrovirals - Conference reports - Lipodystrophy and Metabolic Complications - Women's health - Intl Workshop on HIV and Women 1st 2011 - 22 January 2011
- The impact of antiretroviral treatment on fertility intentions in South Africa Antiretrovirals - Conference reports - PMTCT and maternal health - Women's health - Intl Workshop on HIV and Women 1st 2011 - 22 January 2011
- Virological findings from the SARA trial of boosted protease inhibitor monotherapy Antiretrovirals - Conference reports - Treatment access - HIV 10 Glasgow 2010 - 22 January 2011
- Nevirapine exposure was not associated with hypersensitivity in patients from Malawi Antiretrovirals - Conference reports - Side effects - HIV 10 Glasgow 2010 - 22 January 2011
- Estimating the number of people in a country or region with HIV who are undiagnosed and in need of ART Antiretrovirals - Conference reports - HIV 10 Glasgow 2010 - 22 January 2011
- Efavirenz versus nevirapine based first line treatment in a South African cohort Antiretrovirals - Conference reports - PMTCT and maternal health - HIV 10 Glasgow 2010 - 22 January 2011
- Impact of antiretroviral PMTCT prophylaxis regimens on subsequent maternal disease progression in Kesho Bora Antiretrovirals - Conference reports - PMTCT and maternal health - 22 January 2011
- Birth outcomes with antiretroviral exposure Antiretrovirals - Conference reports - PMTCT and maternal health - 22 January 2011
- Efavirenz-based regimens among women of reproductive age receiving ART in Johannesburg Antiretrovirals - Conference reports - PMTCT and maternal health - Women's health - World AIDS 18 Vienna 2010 - 22 January 2011
- Treatment reduces infections by over 90%: a theme that is here to stay Antiretrovirals - Conference reports - Prevention - Transmission - CROI (Retrovirus) 17 San Francisco 2010 - 2 April 2010
- ACTG 5205: atazanavir/ritonavir vs efavirenz in treatment naïve patients Antiretrovirals - Conference reports - CROI (Retrovirus) 17 San Francisco 2010 - 2 April 2010
- Pipeline compounds and new approaches to treatment Antiretrovirals - Conference reports - CROI (Retrovirus) 17 San Francisco 2010 - 2 April 2010
- Model predicts rate of transmitted drug resistant virus in resource-limited settings Antiretrovirals - Conference reports - Resistance - CROI (Retrovirus) 17 San Francisco 2010 - 6 January 2010
- More concerning research on the Free State ART programme Antiretrovirals - Conference reports - Treatment access - CROI (Retrovirus) 17 San Francisco 2010 - 6 January 2010
- Once-daily darunavir/r monotherapy is suboptimal as initial regimen in treatment-naïve people Antiretrovirals - Conference reports - ECAS 12 Cologne 2009 - 6 January 2010
- Gender-based differences in patients receiving antiretroviral therapy Antiretrovirals - Conference reports - Women's health - 6 January 2010
- Pilot PK study of two generic paediatric formulations of lopinavir/ritonavir vs originator products Antiretrovirals - Conference reports - Paediatric care - ECAS 12 Cologne 2009 - 6 January 2010
- TMC278 did not show teratogenic potential in animal models Antiretrovirals - Conference reports - PMTCT and maternal health - ECAS 12 Cologne 2009 - 6 January 2010
- Five-year survival rates of 87% without routine CD4 or laboratory monitoring in DART study demonstrate an important model for ARV access programmes Antiretrovirals - Conference reports - IAS 5 Cape Town 2009 - 1 July 2009
- Biomarkers associated with mortality: long-term follow up from SMART Antiretrovirals - Conference reports - HIV pathogenesis - IAS 5 Cape Town 2009 - 1 July 2009
- NA ACCORD results support the importance of the START study: response to researchers Antiretrovirals - Conference reports - CROI (Retrovirus) 16 Montreal 2009 - 22 April 2009
- How much (or how little) ritonavir do you need to boost another PI? Antiretrovirals - Conference reports - PK Workshop 10th Amsterdam 2009 - 22 April 2009
- Summary of antiretroviral studies at Glasgow Antiretrovirals - Conference reports - HIV 9 Glasgow 2008 - 22 January 2009
- EMEA supports extension of D:A:D study until at least 2012 and the new remit to include non-AIDS cancers and kidney disease Antiretrovirals - 22 January 2009
- Applications to approve non-refrigerated ritonavir submitted to EMEA and FDA Antiretrovirals - 22 January 2009
- OCTANE Trial DSMB finds ritonavir boosted lopinavir superior to nevirapine in HIV-positive women previously exposed to single dose nevirapine Antiretrovirals - Special reports - 22 September 2008
- Other antiretroviral studies at ICAAC Antiretrovirals - Conference reports - ICAAC 48th Washington 2008 - 22 September 2008
- Abacavir and heart disease: SMART study supports an abacavir-associated increased risk of cardiovascular disease Antiretrovirals - Conference reports - Side effects - World AIDS 17 Mexico City 2008 - 22 September 2008
- Antiretrovirals calculated to extend life expectancy by 35 years Antiretrovirals - 22 September 2008
- Baseline renal insufficiency and mortality risk in HIV-positive adults in Zambia Antiretrovirals - 22 September 2008
- Inflammatory and coagulation biomarkers linked to mortality in large treatment interruption trial Antiretrovirals - 22 September 2008
- Increased risk of myocardial infarction associated with abacavir and ddI Antiretrovirals - Conference reports - CROI (Retrovirus) 15 Boston 2008 - 22 January 2008
- Atazanavir/r vs lopinavir/r in treatment-naive patients: 48 week results Antiretrovirals - Conference reports - CROI (Retrovirus) 15 Boston 2008 - 22 January 2008
- Baseline inflammation and coagulation markers and changes over four weeks during a treatment interruption are strongly linked to HIV viraemia and risk of mortality Antiretrovirals - Conference reports - CROI (Retrovirus) 15 Boston 2008 - 22 January 2008
- Restarting treatment after an interruption reduces the risk of serious events but CD4 recovery falls short of baseline levels Antiretrovirals - Conference reports - CROI (Retrovirus) 15 Boston 2008 - 22 January 2008
- Immediate HAART reduces death and AIDS progression over 48 weeks in patients with acute OIs Antiretrovirals - Conference reports - CROI (Retrovirus) 15 Boston 2008 - 22 January 2008
- Integrase inhibitor resistance and cross-resistance: weighing viral fitness and the option to benefit from second-generation compounds Antiretrovirals - Conference reports - Intl Drug Resistance Workshop 17 Sitges 2008 - 22 January 2008